Ontology highlight
ABSTRACT: Background
Two recent randomized trials produced discordant results when testing the benefits and harms of treatment to reduce blood pressure (BP) in patients with cardiovascular disease (CVD).Objective
To perform a theoretical modeling study to identify whether large, clinically important differences in benefit and harm among patients (heterogeneous treatment effects [HTEs]) can be hidden in, and explain discordant results between, treat-to-target BP trials.Design
Microsimulation.Data sources
Results of 2 trials comparing standard (systolic BP target <140 mm Hg) with intensive (systolic BP target <120 mm Hg) BP treatment and data from the National Health and Nutrition Examination Survey (2013 to 2014).Target population
U.S. adults.Time horizon</
SUBMITTER: Basu S
PROVIDER: S-EPMC5815372 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature